[IKT] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -37.23%
YoY- -1,288.80%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 CAGR
Revenue 240 124 167 591 1,345 691 797 -45.12%
PBT -430 -1,212 -2,344 -1,736 -1,265 -125 45 -
Tax -422 -1,205 -2,339 -1,733 0 -12 0 -
NP -430 -1,212 -2,344 -1,736 -1,265 -125 45 -
Tax Rate - - - - - - 0.00% -
Total Cost 670 1,337 2,511 2,327 2,610 816 753 -5.67%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 CAGR
NP Margin -178.97 -974.37 -1,404.30 -293.75 -94.02 -18.08 5.60 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 31/03/18 31/12/17 CAGR
EPS -0.32 -0.89 -1.72 -1.27 -0.74 -0.10 0.03 -
EPS Diluted -0.32 -0.89 -1.72 -1.27 -0.74 -0.10 0.03 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.